Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD
NCT ID: NCT00585299
Last Updated: 2014-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4 participants
INTERVENTIONAL
2006-10-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Weight Loss Surgery in Adolescents With NAFLD
NCT02952170
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008
Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation
NCT02133144
Weight Management in Nonalcoholic Steatohepatitis
NCT00266019
Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
NCT05842850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-fat diet
20% kcals from fat diet followed for 8 weeks then 8 weeks of maintenance diet with visits to dietitian every other week
Low-fat diet
20% calorie from fat diet followed for 8 weeks then maintenance diet for additional 8 weeks
Traditional diet
Traditional low-fat diet with dietitian follow-up in 16 weeks
Traditional
Traditional low-fat diet given and dietitian follows up in 16 weeks
Traditional diet
Traditional low-fat diet with dietitian follow-up in 16 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-fat diet
20% calorie from fat diet followed for 8 weeks then maintenance diet for additional 8 weeks
Traditional diet
Traditional low-fat diet with dietitian follow-up in 16 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smoking
* BMI \>95th percentile for age and gender, but BMI \<40
* Suspicion of fatty liver, with a high ALT (\>35)
* Normal glucose tolerance or prediabetes (impaired glucose tolerance or impaired fasting glucose)
Exclusion Criteria
* Pregnant or lactating females
* Current medications except oral anti-diabetic medications and hormonal birth control
* Lipid-lowering medication that increases liver enzymes
* Significant kidney dysfunction (creatinine \>1.5 mg/dL)
* Current heavy ethanol use or recent history of binge drinking
* History or evidence of hepatitis A, B, or C, Wilson's Disease, or alpha-1-antitrypsin deficiency
* Known to be HIV positive
* Symptomatic angina pectoris or cardiac insufficiency as defined by the NYHA classification as Functional Class III or IV
* Major vascular event within 6 months of screening (e.g. MI, stroke)
* Active cancer within 5 years prior to screening
* Current systemic disease, including type 1 or 2 diabetes
* Enrolled in another research study within 1 month prior to screening
* Implanted paramagnetic material (all subjects will need to fill out the Yale Magnetic Resonance Center safety checklist)
* Anemia (HCT \<35%)
10 Years
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sonia Caprio, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University School of Medicine
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0212023115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.